Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > New Press Release - Spectral Medical Provides January Tigris Trial Update

<< Previous

Bullboard Posts

Next >>

Comment by seniorcitizen11on Jan 31, 2024 11:59am

149 Views

Post# 35855054

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Provides January Tigris Trial Update

Do I have this right Stocktree? You perform public service for free? You are not a shareholder? You do not beleive that EDT / PMX / EAA is a good investment and that management is performing. Your mission / reason for posting is to protect retail shareholders inclined to invest in Spectral from those who are heavily invested longs. Ignore button is not required, Your shtick is too obvious.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity